Moderna Inc. undefined said Thursday it had a cash position of about $15 billion as of Aug. 31. The company made the disclosure as it offered an update on...
Moderna Inc.
said Thursday it had a cash position of about $15 billion as of Aug. 31. The company made the disclosure as it offered an update on its line of product candidates based on mRNA technology, that includes a vaccine against COVID-19, the first Moderna product to win authorization from the U.S. Food and Drug Administration. In a statement released ahead of an R&D day, the company highlighted a new product candidate that would combine a COVID-19 booster with a seasonal flu booster vaccine.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Do You Need to Space Out Your Flu Shot and COVID Booster? We Asked ExpertsExperts say it's safe to get the flu shot and COVID booster within days or weeks of each other or even to receive both at the same time.
Weiterlesen »
Novavax begins early-stage trial for combined flu/COVID-19 vaccineTrial results are expected in the first half of 2022.
Weiterlesen »
Novavax begins early-stage trial for combined flu/Covid vaccineTrial results are expected in the first half of 2022.
Weiterlesen »
Novavax begins early-stage trial for combined influenza/COVID-19 vaccineVaccine developer Novavax Inc said on Wednesday it has initiated an early-stage study to test its combined flu and COVID-19 vaccine.
Weiterlesen »
How many deaths can we take?Are we ready to live with Covid-19 like it's the flu, as vaccination rates cut the number of hospitalizations and deaths?
Weiterlesen »
The models that turned Instagram into their DIY catwalkNew York Fashion Week marks a tentative return - but how did supermodels keep working through Covid?
Weiterlesen »